Derryl Roderick
Thursday, 22 October 2015
A CEO's View On Amgen's Quest To Pioneer The Next Cancer Immunotherapy
Amgen is expected to win approval soon for a new type of virus-based cancer treatment. Genelux is among the many biotech companies that hope to follow Amgen's lead.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment